Other languages ANI Pharmaceuticals, Inc.

Equities

ANIP

US00182C1036

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
65.36 ^USD	+0.63%		-0.18%	+18.53%

17/04	Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing	MT
09/04	ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing	18/04
ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension	09/04
Ani Pharmaceuticals Insider Sold Shares Worth $1,345,000, According to a Recent SEC Filing	03/04
ANI Pharmaceuticals, Inc. Announces the Launch of Levofloxacin Oral Solution, USP	27/03
Ani Pharmaceuticals Insider Sold Shares Worth $671,700, According to a Recent SEC Filing	12/03
Ani Pharmaceuticals Insider Sold Shares Worth $2,630,864, According to a Recent SEC Filing	08/03
Ani Pharmaceuticals Insider Sold Shares Worth $456,400, According to a Recent SEC Filing	07/03
Ani Pharmaceuticals Insider Sold Shares Worth $330,000, According to a Recent SEC Filing	07/03
Sector Update: Health Care Stocks Decline Late Afternoon	01/03
Sector Update: Health Care Stocks Retreat Thursday Afternoon	01/03
ANI Pharmaceuticals Shares Rise After Q4 Adjusted Earnings, Net Revenue Beat Forecasts	29/02
ANI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
ANI Pharmaceuticals, Inc. Provides Earnings Guidance for the Year 2024	29/02
ANI Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
Ani Pharmaceuticals Insider Sold Shares Worth $1,416,466, According to a Recent SEC Filing	24/01
ANI Pharmaceuticals Launches Pentoxifylline Extended-Release Tablets	23/01
ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP	23/01
Ani Pharmaceuticals Insider Sold Shares Worth $1,370,305, According to a Recent SEC Filing	19/01
ANI Pharmaceuticals Receives US FDA Approval for Indomethacin Oral Suspension	16/01
ANI Pharmaceuticals, Inc. Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USP	16/01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ANI Pharmaceuticals, Inc.

Equities

ANIP

US00182C1036

Other languages

Filters